Novavax Market Cap

Novavax has a market cap or net worth of 1.12 billion as of January 31, 2025. Its market cap has increased by 183.97% in one year.

Market Cap

1.12B

Enterprise Value

599.12M

Revenue

660.44M

Ranking

n/a

PE Ratio

n/a

Stock Price

11.90

Market Cap Chart

Since July 25, 1996, Novavax's market cap has increased from 22.60M to 1.12B, an increase of 4,855.28%. That is a compound annual growth rate of 14.66%.

Market Cap History

Date	Market Cap	% Change
Jan 31, 2025	1.12B	8.86%
Dec 31, 2024	1.03B	129.81%
Dec 29, 2023	447.65M	-38.98%
Dec 30, 2022	733.56M	-90.82%
Dec 31, 2021	7.99B	167.41%
Dec 31, 2020	2.99B	4,139.68%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	175.89B
Shell	163.79B
HSBC Holdings	148.66B
Unilever	120.06B
Rio Tinto Group	83.08B
RELX PLC	74.57B
British American Tobacco p.l.c.	70.36B
BP p.l.c.	66.33B

Market Cap Rankings